Skip to main content
Premium Trial:

Request an Annual Quote

GenVault Nabs $18M in VC Cash; Funds Will Help Commercialize Biosample Tech

This article has been updated from a previous version, which omitted the fact that Domain Associates also participated in the current funding round.
 
NEW YORK (GenomeWeb News) — GenVault today said it has secured $18 million in financing from Domain Associates and QuestMark Partners, a new investor.  
 
As a result, Benjamin Schapiro, a partner at QuestMark, will join GenVault’s board of directors.
 
GenVault makes a dry-state platform that extracts, preserves, recovers, and distributes biosamples. GenVault said it plans to use the cash to help it commercialize the platform.
 
QuestMark focuses its investing on “late-stage growth companies in emerging markets,” GenVault said.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.